Cause or Effect: Which Genetic Changes Are Associated With Cancer?

authors:

avatar David J. Timson 1 , 2 , *

Medical Biology Center, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom
Institute for Global Food Security, Queen’s University Belfast, Belfast, United Kingdom
Gene, Cell and Tissue: Vol.1, issue 3; e23818
published online: October 22, 2014
article type: Letter
received: September 22, 2014
accepted: September 28, 2014
DOI: https://doi.org/10.17795/gct-23818

how to cite: J. Timson D. Cause or Effect: Which Genetic Changes Are Associated With Cancer?. Gene Cell Tissue. 2014;1(3):e23818. https://doi.org/10.17795/gct-23818.

Acknowledgements

References

  • 1.

    Lorente D, De Bono JS. Molecular alterations and emerging targets in castration resistant prostate cancer. Eur J Cancer. 2014;50(4):753-64. [PubMed ID: 24418724]. https://doi.org/10.1016/j.ejca.2013.12.004.

  • 2.

    Gaya JM, Ahallal Y, Sanchez-Salas R, Barret E, Rozet F, Galiano M, et al. Current, new and novel therapy for castration-resistant prostate cancer. Expert Rev Anticancer Ther. 2013;13(7):819-27. [PubMed ID: 23875660]. https://doi.org/10.1586/14737140.2013.811154.

  • 3.

    Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014;1(2). ee19169.

  • 4.

    Daugherty SE, Hayes RB, Yeager M, Andriole GL, Chatterjee N, Huang WY, et al. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate. 2007;67(8):849-54. [PubMed ID: 17407163]. https://doi.org/10.1002/pros.20537.

  • 5.

    Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 2002;32(4):581-3. [PubMed ID: 12415269]. https://doi.org/10.1038/ng1021.

  • 6.

    Silverman RH. Implications for RNase L in prostate cancer biology. Biochemistry. 2003;42(7):1805-12. [PubMed ID: 12590567]. https://doi.org/10.1021/bi027147i.

  • 7.

    Elliott SF, Allen G, Timson DJ. Biochemical analysis of the interactions of IQGAP1 C-terminal domain with CDC42. World J Biol Chem. 2012;3(3):53-60. [PubMed ID: 22451851]. https://doi.org/10.4331/wjbc.v3.i3.53.

  • 8.

    Pey AL, Megarity CF, Timson DJ. FAD binding overcomes defects in activity and stability displayed by cancer-associated variants of human NQO1. Biochim Biophys Acta. 2014;1842(11):2163-73. [PubMed ID: 25179580]. https://doi.org/10.1016/j.bbadis.2014.08.011.

  • 9.

    Lienhart WD, Gudipati V, Uhl MK, Binter A, A. Pulido S, Saf R, et al. Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase. FEBS J. 2014;281(20):4691-704. [PubMed ID: 25143260]. https://doi.org/10.1111/febs.12975.

  • 10.

    Ringe D, Petsko GA. What are pharmacological chaperones and why are they interesting? J Biol. 2009;8(9):80. [PubMed ID: 19833004]. https://doi.org/10.1186/jbiol186.